We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $69.2B
1-Year Est. Return 41.24%
This Fund
S&P 500
This Quarter Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
Cap. Flow
-$7.07B
Cap. Flow %
-10.23%
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Miscellaneous 27.25%
3 Industrials 6.93%
4 Consumer Staples 6.67%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDCC icon
726
InterDigital
IDCC
$8.72B
$1.52M ﹤0.01%
5,365
-352
-6% -$105K
FCFS icon
727
FirstCash
FCFS
$9.79B
$1.5M ﹤0.01%
6,918
-378
-5% -$82.1K
ENS icon
728
EnerSys
ENS
$6.56B
$1.48M ﹤0.01%
6,332
-478
-7% -$104K
DVA icon
729
DaVita
DVA
$11.7B
$1.47M ﹤0.01%
6,603
+1,339
+25% +$243K
ROIV icon
730
Roivant Sciences
ROIV
$25.2B
$1.46M ﹤0.01%
41,371
-8,731
-17% -$258K
GLBE icon
731
Global E Online
GLBE
$6.44B
$1.44M ﹤0.01%
41,495
+15,674
+61% +$496K
APGE
732
DELISTED
Apogee Therapeutics
APGE
$1.42M ﹤0.01%
10,733
+1,847
+21% +$166K
TEX icon
733
Terex
TEX
$7.23B
$1.42M ﹤0.01%
19,598
-1,217
-6% -$76.1K
PRAX icon
734
Praxis Precision Medicines
PRAX
$9.82B
$1.41M ﹤0.01%
4,208
-780
-16% -$247K
CVLT icon
735
Commault Systems
CVLT
$5.65B
$1.36M ﹤0.01%
9,622
-1,416
-13% -$152K
ORA icon
736
Ormat Technologies
ORA
$6.48B
$1.35M ﹤0.01%
12,389
-685
-5% -$84.9K
PTGX icon
737
Protagonist Therapeutics
PTGX
$9.43B
$1.33M ﹤0.01%
10,878
-1,040
-9% -$109K
ESE icon
738
ESCO Technologies
ESE
$7.1B
$1.32M ﹤0.01%
3,774
-272
-7% -$85.1K
RVMD icon
739
Revolution Medicines
RVMD
$45B
$1.31M ﹤0.01%
6,970
-1,895
-21% -$277K
HQY icon
740
HealthEquity
HQY
$7.95B
$1.3M ﹤0.01%
14,447
-1,202
-8% -$102K
HIMS icon
741
Hims & Hers Health
HIMS
$6.47B
$1.3M ﹤0.01%
37,512
-1,105
-3% -$29.7K
FROG icon
742
JFrog
FROG
$10.8B
$1.3M ﹤0.01%
+14,302
New +$929K
TWLO icon
743
Twilio
TWLO
$35.8B
$1.28M ﹤0.01%
6,227
-12
-0.2% -$2.13K
RIOT icon
744
Riot Platforms
RIOT
$8.18B
$1.28M ﹤0.01%
46,766
-3,805
-8% -$85.8K
PCVX icon
745
Vaxcyte
PCVX
$9.1B
$1.28M ﹤0.01%
21,990
-2,459
-10% -$134K
FLR icon
746
Fluor
FLR
$7.51B
$1.27M ﹤0.01%
24,330
-5,488
-18% -$269K
WYNN icon
747
Wynn Resorts
WYNN
$9.43B
$1.25M ﹤0.01%
12,917
+329
+3% +$33.9K
KYMR icon
748
Kymera Therapeutics
KYMR
$9.76B
$1.25M ﹤0.01%
10,900
-1,062
-9% -$91.2K
JD icon
749
JD.com
JD
$38.2B
$1.25M ﹤0.01%
48,930
+5,494
+13% +$162K
LNTH icon
750
Lantheus
LNTH
$6.59B
$1.23M ﹤0.01%
11,126
-1,009
-8% -$94K

Similar funds

ProShare Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.

  • ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
  • ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
  • ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
  • ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
  • ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
  • ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
  • ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.